Addiction Medicine
Latest News
Moms’ cannabis use in pregnancy tied to anxiety and hyperactivity in offspring
May have epigenetic immunomodulatory effects affecting neurodevelopment
News
U.S. overdose deaths hit an all-time high
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
Latest News
HCV in pregnancy: One piece of a bigger problem
“These data also enable us to step back a bit from HCV and look at the landscape of how the opioid crisis continues to grow in complexity and...
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
Conference Coverage
Cannabis use: Messages remain mixed across diagnoses
Medscape Live and this news organization are owned by the same parent company. Dr. Martinez and Dr. Sarris reported no financial conflicts of...
From the Journals
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
News
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
From the Journals
Substance abuse boosts COVID hospitalization, death risk, even after vaccination
Investigators found about twice as many individuals with an SUD had a breakthrough COVID-19 infection as their counterparts without an SUD.
From the Journals
Telehealth a game changer for addiction treatment?
“We still need more research to confirm the benefits of telehealth and to determine under what conditions telehealth is best used.”
Feature
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.